科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background Chronic itch is difficult to treat. Low-concentration topical capsaicin (0.006-0.05%) has previously been applied in itch therapy but evidence on its efficacy is contradictory. Objectives This vehicle-controlled, double-blinded study investigated the effect of topical capsaicin 8% after 1- and 24-h application on evoked itch, neurogenic inflammation and itch-associated dysaesthesia. Methods Sixteen healthy volunteers (aged 22.0.5 years, nine female) were treated with capsaicin for 1 h and 24 h, and vehicle for 24 h on each volar forearm. Subsequently, histamine (1%, administered prick test lancets) and cowhage (40-45 spicules) were applied to the pretreated areas. Evoked itch and pain intensities were recorded for 10 min using a visual analogue scale (0-10 cm), while sensitivity to touch-evoked itch was evaluated using von Frey filaments before and after itch provocations. Neurogenic inflammation was assessed using perfusion imaging. Results In the vehicle areas peak itch responses to histamine and cowhage were 4.67 +/- 0.58 and 5.15 +/- 0.71, respectively. Capsaicin pretreatment reduced peak itch responses to histamine and cowhage after 24-h pretreatment to 1.41 +/- 0.58 (P = 0.003) and 0.81 +/- 0.18, (P < 0.001), respectively. Capsaicin pretreatment for 1 h reduced only cowhage-induced itch (P = 0.023). Furthermore, 24-h capsaicin pretreatment abolished punctuate hyperknesis and lowered histamine-induced neurogenic inflammation but did not affect weal reactions. Conclusions Topical capsaicin 8% pretreatment for 24 h reduced histaminergic and nonhistaminergic itch by about 75%, while a significant reduction (similar to 60%) was achieved for only nonhistaminergic itch in a standard 1-h treatment. Further investigations are needed to elucidate the clinical potential of high-concentration capsaicin as an antipruritic.
